Novo Nordisk open to New York listing upgrade, CEO Doustdar tells FT

berlingske.dk

Lean Right

Factuality

Ownership

A possible change in Novo's US listing, a dispute over star's billions and a major Danish company sale. Welcome to today's update.

Globo

Lean Right

Factuality

Ownership

New Nordisk is open to considering a direct listing on the New York Stock Exchange, replacing receipts of shares deposited in the United States (ADRs), through which American investors are currently negotiating their roles, said President Mike Doustdar to the Financial Times (FT), in an interview published on Wednesday (23). The US responds for more than half of New's revenue and for most of the sales of its diabetes and obesity drugs, but the D…

Folha de S.Paulo

Factuality

Ownership

New is open to the possibility of expanding its presence in the New York Stock Exchange as part of efforts to strengthen the profile of the Danish manufacturer of weight loss medicines in the United States, after a similar initiative adopted by the British rival AstraZeneca earlier this year. Read more (09/23/2026

Biznis.rs

Factuality

Ownership

Novo Nordisk is considering listing its shares directly on the New York Stock Exchange, rather than having American investors trade them through depositary receipts. The company's CEO, Mike Doustdar, said that such a move has certain advantages, but emphasized that the company is currently not actively working on its implementation. The idea is being considered...